20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Shares of Bristol-Myers Squibb (NYSE:BMY) decreased 0.1% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 18.40% over the past year to $1.93, which beat the estimate of $1.91.
Revenue of $11,703,000,000 higher by 15.54% year over year, which beat the estimate of $11,330,000,000.
Guidance
Bristol Myers Squibb reaffirmed FY21 adjusted EPS guidance range of $7.35-$7.55.
How To Listen To The Conference Call
Date: Jul 28, 2021
Time: 08:00 AM
Technicals
52-week high: $68.53
52-week low: $56.75
Price action over last quarter: Up 7.96%
Company Overview
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!